Literature DB >> 18977436

The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.

P J Salústio1, G Feio, J L Figueirinhas, J F Pinto, H M Cabral Marques.   

Abstract

The work aims to prove the complexation of two model drugs (ibuprofen, IB and indomethacin, IN) by beta-cyclodextrin (betaCD), and the effect of water in such a process, and makes a comparison of their complexation yields. Two methods were considered: kneading of a binary mixture of the drug, betaCD, and inclusion of either IB or IN in aqueous solutions of betaCD. In the latter method water was removed by air stream, spray-drying and freeze-drying. To prove the formation of complexes in final products, optical microscopy, UV spectroscopy, IR spectroscopy, DSC, X-ray and NMR were considered. Each powder was added to an acidic solution (pH=2) to quantify the concentration of the drug inside betaCD cavity. Other media (pH=5 and 7) were used to prove the existence of drug not complexed in each powder, as the drugs solubility increases with the pH. It was observed that complexation occurred in all powders, and that the fraction of drug inside the betaCD did not depend neither on the method of complexation nor on the processes of drying considered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18977436     DOI: 10.1016/j.ejpb.2008.09.027

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  14 in total

Review 1.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

2.  β-cyclodextrin coating: improving biocompatibility of magnetic nanocomposites for biomedical applications.

Authors:  Mariela Agotegaray; María Gabriela Blanco; Adrián Campelo; Elba García; Roberto Zysler; Virginia Massheimer; María José De Rosa; Verónica Lassalle
Journal:  J Mater Sci Mater Med       Date:  2020-01-30       Impact factor: 3.896

3.  Experimental and computational studies of physicochemical properties influence NSAID-cyclodextrin complexation.

Authors:  Linda A Felton; Carmen Popescu; Cody Wiley; Emilio Xavier Esposito; Philippe Lefevre; Anton J Hopfinger
Journal:  AAPS PharmSciTech       Date:  2014-04-10       Impact factor: 3.246

4.  Improvement of Meloxicam Solubility Using a β-Cyclodextrin Complex Prepared via the Kneading Method and Incorporated into an Orally Disintegrating Tablet.

Authors:  Ahmad Ainurofiq; Syaiful Choiri; Muhamad Ali Azhari; Chaterin Romauli Siagian; Bambang Budi Suryadi; Fea Prihapsara; Sholichah Rohmani
Journal:  Adv Pharm Bull       Date:  2016-09-25

5.  Binding of sulfamethazine to β-cyclodextrin and methyl-β-cyclodextrin.

Authors:  Ariana Zoppi; Alicia Delrivo; Virginia Aiassa; Marcela Raquel Longhi
Journal:  AAPS PharmSciTech       Date:  2013-04-19       Impact factor: 3.246

6.  Synthesis and Characterization of the Inclusion Complex of β-cyclodextrin and Azomethine.

Authors:  Kavirajaa Pandian Sambasevam; Sharifah Mohamad; Norazilawati Muhamad Sarih; Nor Atiqah Ismail
Journal:  Int J Mol Sci       Date:  2013-02-07       Impact factor: 5.923

7.  A green sorbent for CO2 capture: α-cyclodextrin-based carbonate in DMSO solution.

Authors:  Ala'a F Eftaiha; Abdussalam K Qaroush; Fatima Alsoubani; Thomas M Pehl; Carsten Troll; Bernhard Rieger; Bassem A Al-Maythalony; Khaleel I Assaf
Journal:  RSC Adv       Date:  2018-11-09       Impact factor: 3.361

8.  Characterization of albendazole-randomly methylated-β-cyclodextrin inclusion complex and in vivo evaluation of its antihelmitic activity in a murine model of Trichinellosis.

Authors:  Agustina García; Darío Leonardi; María D Vasconi; Lucila I Hinrichsen; María C Lamas
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

9.  Co-grinding Effect on Crystalline Zaltoprofen with β-cyclodextrin/Cucurbit[7]uril in Tablet Formulation.

Authors:  Shanshan Li; Xiang Lin; Kailin Xu; Jiawei He; Hongqin Yang; Hui Li
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

10.  Modified β-cyclodextrin inclusion complex to improve the physicochemical properties of albendazole. complete in vitro evaluation and characterization.

Authors:  Agustina García; Darío Leonardi; Mario Oscar Salazar; María Celina Lamas
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.